Rutgers Leads International Conference on Alzheimer’s Disease in Israel
July 2, 2025
A Rutgers-led conference on Alzheimer's disease held in Tel Aviv, Israel, earlier this month provided a platform for leading researchers and students from both the United States and Israel to share their latest findings on understanding, preventing, and treating Alzheimer's.
The brainchild of Mark Gluck, professor of Neuroscience at Rutgers University-Newark and Michal Schnaider Beeri, professor of Neurology at Rutgers Biomedical and Health Sciences, the conference's primary goal was to expand collaboration between American and Israeli scientists seeking a cure for Alzhiemer's disease.
The meeting was hosted locally by Tel Aviv University and organized by Illana Gozes, professor of Molecular Genetics, with support from Hermona Soreq, professor of Molecular Neuroscience at Hebrew University of Jerusalem. Scientists and doctors travelled from Nigeria, the United Kingdom, Germany and the across the United States to attend the meeting.